Vericel Corp. (VCEL)
38.73
+1.35
(+3.61%)
USD |
NASDAQ |
Jun 11, 16:00
38.73
0.00 (0.00%)
After-Hours: 18:34
Vericel Gross Profit Margin (Quarterly) : 72.00% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 72.00% |
| December 31, 2025 | 78.70% |
| September 30, 2025 | 73.46% |
| June 30, 2025 | 73.71% |
| March 31, 2025 | 68.96% |
| December 31, 2024 | 77.61% |
| September 30, 2024 | 71.93% |
| June 30, 2024 | 69.50% |
| March 31, 2024 | 68.94% |
| December 31, 2023 | 74.63% |
| September 30, 2023 | 67.15% |
| June 30, 2023 | 65.20% |
| March 31, 2023 | 64.66% |
| December 31, 2022 | 72.59% |
| September 30, 2022 | 65.45% |
| June 30, 2022 | 61.69% |
| March 31, 2022 | 65.01% |
| December 31, 2021 | 71.51% |
| September 30, 2021 | 64.04% |
| June 30, 2021 | 68.09% |
| March 31, 2021 | 66.49% |
| December 31, 2020 | 74.39% |
| September 30, 2020 | 69.66% |
| June 30, 2020 | 56.73% |
| March 31, 2020 | 62.81% |
| Date | Value |
|---|---|
| December 31, 2019 | 73.13% |
| September 30, 2019 | 69.43% |
| June 30, 2019 | 65.50% |
| March 31, 2019 | 60.39% |
| December 31, 2018 | 72.46% |
| September 30, 2018 | 63.81% |
| June 30, 2018 | 59.36% |
| March 31, 2018 | 57.47% |
| December 31, 2017 | 64.07% |
| September 30, 2017 | 49.61% |
| June 30, 2017 | 54.76% |
| March 31, 2017 | 24.06% |
| December 31, 2016 | 54.06% |
| September 30, 2016 | 37.27% |
| June 30, 2016 | 43.07% |
| March 31, 2016 | 53.50% |
| December 31, 2015 | 53.12% |
| September 30, 2015 | 40.12% |
| June 30, 2015 | 49.22% |
| March 31, 2015 | 48.68% |
| December 31, 2014 | 54.09% |
| September 30, 2014 | 43.76% |
| June 30, 2014 | 41.13% |
| March 31, 2014 | |
| December 31, 2013 | -1.19K% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -- |
| Krystal Biotech, Inc. | 93.26% |
| TG Therapeutics, Inc. | 83.65% |
| Gyre Therapeutics, Inc. | 94.55% |
| ACADIA Pharmaceuticals, Inc. | 90.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.56% |
| Return on Assets | 4.69% |
| Return on Invested Capital | 5.03% |
| Profit Margin (Quarterly) | -9.21% |
| Operating Margin (Quarterly) | -11.79% |
| Return on Net Operating Assets | 8.10% |